Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antigen-Pulsed Autologous Dendritic Cells in Metastatic Melanoma
NCT00003229Phase 2Completed
- Sponsor
- Duke University
- Start
- Jul 1997
- Primary completion
- Apr 2000
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine in melanoma, sponsored by Duke University. Started Jul 1997; status: completed.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00003229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003229.